Relative Bioavailability Study of HR19042 in Healthy Subjects

Clinical trial NCT06922305 · COMPLETED

Trial details

NCT number: NCT06922305
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Primary IgA Nephropathy; Autoimmune Hepatitis

Start date: 2023-12-27
Primary completion: 2024-01-25
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.